The evidence suggests that weight loss is the primary driver of the reproductive improvements seen with semaglutide, as substantial weight reduction is known to improve hormone balance, ovarian function and fertility in women with PMOS. Clare Thompson, MBBS, BSc, nMRCGP However, GLP-1 drugs may also have direct effects on reproductive health via mechanisms such as insulin signalling and ovarian function
We help patients develop realistic exercise and lifestyle plans that fit their schedule, fitness level, and goals
Glucose, sugar, and artificial sweeteners
Scirica BM, Braunwald E, Raz I, Cavender MA, Morrow DA, Jarolim P, Udell JA, Mosenzon O, Im K, Umez-Eronini AA, Pollack PS, Hirshberg B, Frederich R, Lewis BS, McGuire DK, Davidson J, Steg PG, Bhatt DL, SAVOR-TIMI 53 Steering Committee and Investigators
Yes, plateaus can happen with any GLP-1 medication, including Wegovy, the version of semaglutide approved for weight loss
B., and Perdew, G